STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

USANA (USNA) files Form 144 for 5,169-share sale via Morgan Stanley

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

USANA Health Sciences (USNA) filer submitted a Form 144 proposing the sale of 5,169 common shares through Morgan Stanley Smith Barney on the NYSE. The shares have an aggregate market value of $165,408 and the issuer reports 18,271,836 shares outstanding, making the sale a small fraction of total shares. The shares were acquired as restricted stock in early February 2025 (944 on 02/07/2025, 2,805 on 02/08/2025 and 1,420 on 02/06/2025) and the approximate sale date is listed as 08/28/2025. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine insider notification of a planned sale; size appears immaterial relative to shares outstanding.

The Form 144 documents a proposed disposition of 5,169 USNA common shares via Morgan Stanley Smith Barney with an aggregated value of $165,408 and an approximate sale date of August 28, 2025. The underlying shares were issued as restricted stock in early February 2025. Compared with the reported 18,271,836 shares outstanding, this represents a very small percentage of the float, indicating the filing is procedural and unlikely to have material market impact. The disclosure includes the customary attestation regarding material nonpublic information, and no other transactions in the prior three months are reported.

TL;DR: Proper Rule 144 notice for planned sale; compliance appears complete but provides limited substantive detail.

The submission lists broker details, exact share counts, acquisition dates and types (restricted stock), and attests to absence of undisclosed material information. These elements satisfy Form 144 requirements for notifying the market of a proposed sale under Rule 144. There is no indication of an adopted trading plan or 10b5-1 scheduling in the remarks, and no prior sales reported in the past three months. From a governance perspective, documentation appears routine and compliant.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does USNA's Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 5,169 common shares through Morgan Stanley Smith Barney with an aggregate market value of $165,408 and an approximate sale date of 08/28/2025.

How many USNA shares are outstanding according to the filing?

The Form 144 reports 18,271,836 shares outstanding.

When and how were the shares being sold acquired?

The shares were acquired as restricted stock from the issuer on 02/06/2025, 02/07/2025, and 02/08/2025 totaling 5,169 shares.

Was any sale of USNA securities reported in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities will be sold.

Which broker is handling the proposed sale of USNA shares?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, 8th Floor, New York, NY 10004.
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

374.57M
10.42M
42.93%
61.22%
3.86%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY